Riskpilot← Back to searchSign inGet full accessLeva I Norr AB
ABActiveOrg 5569518250Midsommarstigen 1Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20135-9 employees
Revenue 2025
SEK 831K
+25% vs 2024
EBITDA margin
37.9%
+170% vs 2024
Equity ratio
77.3%
Financial strength
Net profit 2025
SEK 240K
+185% vs 2024
| Revenue | SEK 831K | +25% |
| EBITDA | SEK 315K | +170% |
| Net profit | SEK 240K | +185% |
| Total assets | SEK 789K | +18% |
| Equity | SEK 610K | +7% |
| Employees | — | — |
Legal name
Leva I Norr AB
Org number
5569518250
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
4 december 2013
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Leva I Norr skall bedriva utbildning inom sjukvård, brandskydd, fallskydd samt försäljning av medicinsk utrustning, exempelvis hjärtstartare.
Address
Midsommarstigen 1
Email
niklas.lindblom@levainorr.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 448 | 834 | 1 535 | 663 | 831 |
| Staff expenses | — | −157 | −224 | −204 | −238 |
| EBITDA | 161 | 152 | 424 | 117 | 315 |
| Depreciation & amort. | −10 | −10 | −7 | −6 | −9 |
| EBIT | 151 | 143 | 417 | 111 | 306 |
| Net financials | — | −1 | 1 | −0 | 0 |
| Profit before tax | 151 | 142 | 417 | 111 | 306 |
| Tax | −31 | −29 | −90 | −27 | −66 |
| Net profit | 120 | 113 | 327 | 84 | 240 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 532 | 505 | 860 | 670 | 789 |
| Equity | 445 | 458 | 685 | 570 | 610 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 86 | 47 | 174 | 101 | 179 |
| Total debt | 86 | 47 | 174 | 101 | 179 |
EBITDA margin
37.9%
This company
15.8%
Market median
+140% vs market
20212025
Equity ratio
77.3%
This company
38.2%
Market median
+102% vs market
20212025
Return on equity
39.4%
This company
18.4%
Market median
+114% vs market
20212025
Net profit margin
28.9%
This company
8.1%
Market median
+257% vs market
20212025
Asset turnover
1.05×
This company
1.12×
Market median
+6% vs market
20212025
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Leva I Norr AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Anders Fredric Rönnholm | Deputy Chief Executive Officer | 0 companies |
| Olof Ingemar Eliasson | Chairman | 0 companies |
| Claes Johan Lindholm | Board of Directors | 0 companies |
| Karl Niklas Lindblom | Board of Directors | 0 companies |
| Per Kristoffer Thylin | Board of Directors | 0 companies |
| Per Magnus Nyberg | Board of Directors | 0 companies |